164 related articles for article (PubMed ID: 20207266)
1. Digital microfluidics: a future technology in the newborn screening laboratory?
Millington DS; Sista R; Eckhardt A; Rouse J; Bali D; Goldberg R; Cotten M; Buckley R; Pamula V
Semin Perinatol; 2010 Apr; 34(2):163-9. PubMed ID: 20207266
[TBL] [Abstract][Full Text] [Related]
2. Novel application of digital microfluidics for the detection of biotinidase deficiency in newborns.
Graham C; Sista RS; Kleinert J; Wu N; Eckhardt A; Bali D; Millington DS; Pamula VK
Clin Biochem; 2013 Dec; 46(18):1889-91. PubMed ID: 24036022
[TBL] [Abstract][Full Text] [Related]
3. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Winger T; Srinivasan V; Bali D; Millington DS; Pamula VK
Clin Chim Acta; 2013 Sep; 424():12-8. PubMed ID: 23660237
[TBL] [Abstract][Full Text] [Related]
4. Digital microfluidic platform for multiplexing enzyme assays: implications for lysosomal storage disease screening in newborns.
Sista RS; Eckhardt AE; Wang T; Graham C; Rouse JL; Norton SM; Srinivasan V; Pollack MG; Tolun AA; Bali D; Millington DS; Pamula VK
Clin Chem; 2011 Oct; 57(10):1444-51. PubMed ID: 21859904
[TBL] [Abstract][Full Text] [Related]
5. Newborn screening for lysosomal storage disorders.
Matern D
Acta Paediatr; 2008 Apr; 97(457):33-7. PubMed ID: 18339185
[TBL] [Abstract][Full Text] [Related]
6. A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders.
Gucciardi A; Legnini E; Di Gangi IM; Corbetta C; Tomanin R; Scarpa M; Giordano G
Biomed Chromatogr; 2014 Aug; 28(8):1131-9. PubMed ID: 24449175
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for lysosomal storage diseases.
Gelb MH; Scott CR; Turecek F
Clin Chem; 2015 Feb; 61(2):335-46. PubMed ID: 25477536
[TBL] [Abstract][Full Text] [Related]
8. Digital microfluidics comes of age: high-throughput screening to bedside diagnostic testing for genetic disorders in newborns.
Millington D; Norton S; Singh R; Sista R; Srinivasan V; Pamula V
Expert Rev Mol Diagn; 2018 Aug; 18(8):701-712. PubMed ID: 30004274
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening of lysosomal storage disorders.
Marsden D; Levy H
Clin Chem; 2010 Jul; 56(7):1071-9. PubMed ID: 20489136
[TBL] [Abstract][Full Text] [Related]
10. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
[TBL] [Abstract][Full Text] [Related]
11. Rapid assays for Gaucher and Hurler diseases in dried blood spots using digital microfluidics.
Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Bali D; Millington DS; Pamula VK
Mol Genet Metab; 2013 Jun; 109(2):218-20. PubMed ID: 23578771
[TBL] [Abstract][Full Text] [Related]
12. Screening of lysosomal storage disorders: application of the online trapping-and-cleanup liquid chromatography/mass spectrometry method for mucopolysaccharidosis I.
Ombrone D; Malvagia S; Funghini S; Giocaliere E; Della Bona ML; Forni G; De Luca A; Villanelli F; Casetta B; Guerrini R; la Marca G
Eur J Mass Spectrom (Chichester); 2013; 19(6):497-503. PubMed ID: 24378468
[TBL] [Abstract][Full Text] [Related]
13. Inborn errors of metabolism and expanded newborn screening: review and update.
Mak CM; Lee HC; Chan AY; Lam CW
Crit Rev Clin Lab Sci; 2013 Nov; 50(6):142-62. PubMed ID: 24295058
[TBL] [Abstract][Full Text] [Related]
14. Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots.
Gelb MH; Lukacs Z; Ranieri E; Schielen PCJI
Int J Neonatal Screen; 2019 Mar; 5(1):. PubMed ID: 30957052
[TBL] [Abstract][Full Text] [Related]
15. Isothermal Amplification Strategies for Detection in Microfluidic Devices.
Sarkar S; Sabhachandani P; Konry T
Trends Biotechnol; 2017 Mar; 35(3):186-189. PubMed ID: 27692899
[TBL] [Abstract][Full Text] [Related]
16. [Mass spectrometry and neonatal screening].
Garnotel R
Ann Biol Clin (Paris); 2015; 73(1):107-11. PubMed ID: 25582727
[TBL] [Abstract][Full Text] [Related]
17. The application of multiplexed, multi-dimensional ultra-high-performance liquid chromatography/tandem mass spectrometry to the high-throughput screening of lysosomal storage disorders in newborn dried bloodspots.
Kasper DC; Herman J; De Jesus VR; Mechtler TP; Metz TF; Shushan B
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):986-94. PubMed ID: 20209662
[TBL] [Abstract][Full Text] [Related]
18. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism.
Chace DH; Kalas TA; Naylor EW
Annu Rev Genomics Hum Genet; 2002; 3():17-45. PubMed ID: 12142359
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a microfluidic immunoassay capable of multiplexing parallel samples in microliter volumes.
Ghodbane M; Stucky EC; Maguire TJ; Schloss RS; Shreiber DI; Zahn JD; Yarmush ML
Lab Chip; 2015 Aug; 15(15):3211-21. PubMed ID: 26130452
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for lysosomal storage disorders.
Matern D; Gavrilov D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
Semin Perinatol; 2015 Apr; 39(3):206-16. PubMed ID: 25891428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
